Sri Lanka, Oct. 16 -- An Indo-Sri Lankan joint venture between India's Zydus Lifesciences Limited and Sunshine Healthcare will invest over US$20 million in a pharmaceutical manufacturing facility in the Board of Investment (BOI) zone in Horana, strengthening Sri Lanka's domestic medicine production capacity and reducing reliance on imported pharmaceuticals.Sri Lanka Travel

Zydus Sunshine Lifesciences (Pvt) Ltd signed an agreement with the BOI on October 13 to establish the facility on a site spanning nearly four acres, with commercial operations expected to commence in 2028, subject to project timelines and regulatory approvals.

The investment is expected to support technology transfer, generate skilled employment and strengthen the res...